GlycoMimetics
GLYC
#10327
Rank
ยฃ7.6 M
Marketcap
ยฃ0.12
Share price
-5.42%
Change (1 day)
-48.18%
Change (1 year)

P/E ratio for GlycoMimetics (GLYC)

P/E ratio as of December 2025 (TTM): -0.3019

According to GlycoMimetics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.301923. At the end of 2022 the company had a P/E ratio of -3.44.

P/E ratio history for GlycoMimetics from 2014 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2022-3.44194.11%
2021-1.17-65.44%
2020-3.39-13.55%
2019-3.92-51.17%
2018-8.03
2016-4.04-52.68%
2015-8.54-26.48%
2014-11.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
bluebird bio
BLUE
-0.2003-33.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
15.1-5,111.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
13.3-4,511.75%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
19.4-6,516.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-0.3467 14.84%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.